Director/PDMR shareholding

September 12, 2018

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 11 September 2018, it purchased 601,582 ordinary shares of 1p each in the capital of the Company ("Ordinary Shares") at 3.60p per Ordinary Share (the “Purchase”). Following the purchase, Vulpes has a total direct and indirect interest in 59,330,879 equivalent to 20.01% of Proteome Sciences' total issued share capital.

Back to News